DBS Group Research analyst Cheria Christi Widjaja has reiterated her “buy” call for Japfa in a research note dated August 24, with a target price of $1.05.

“We reiterate our “buy” recommendation on Japfa as we expect its resilient performance to continue in 2H2021 supported by its China dairy operation which will mitigate the potential short-term weakness in other operations due to Covid-19 situations,” Widjaja says.

The way she sees it, while Japfa’s Indonesian poultry operations will face near-term headwinds in 3Q2021 due to stricter movement restrictions. In addition, she expects growth from its Vietnam swine operations, which saw sales for swine fattening and swine feed grow by 29% and 43% y-o-y respectively in 1H2021, to slow down in 2Q2021 due to the worsening Covid-19 situation in Vietnam. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook